Anastasios Spanos
Overview
Explore the profile of Anastasios Spanos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
18
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spanos M, Gokulnath P, Li G, Hutchins E, Meechoovet B, Sheng Q, et al.
medRxiv
. 2024 Oct;
PMID: 39371135
The ability to track disease without tissue biopsy in patients is a major goal in biology and medicine. Here, we identify and characterize cardiomyocyte-derived extracellular vesicles in circulation (EVs; "cardiovesicles")...
2.
Tsiachris D, Chatzantonis G, Antoniou C, Lalos H, Bogdanis G, Nikolaou P, et al.
Hellenic J Cardiol
. 2022 Oct;
68:63-65.
PMID: 36181997
No abstract available.
3.
Doupis J, Festas G, Papakonstantinou P, Andrianesis V, Efthymiou V, Spanos A, et al.
Metab Syndr Relat Disord
. 2020 Sep;
18(10):493-497.
PMID: 32924774
Dietary habits and physical exercise have independently been recognized as important contributors to weight loss. However, the relative effect of diet and exercise on body weight is still unclear and...
4.
Papakonstantinou P, Apostolou I, Papathanasiou L, Papagikas P, Hamilos M, Aggeli C, et al.
Hellenic J Cardiol
. 2019 Mar;
60(5):324-326.
PMID: 30853607
We report the first case of real-time FFRangio™ application in Greece applied in a patient with tandem lesions in the proximal segment of the left anterior descendent artery.
5.
Toutouzas K, Klettas D, Anousakis-Vlachochristou N, Melidis K, Azilazian Z, Asimomiti M, et al.
Hellenic J Cardiol
. 2017 Feb;
58(1):80-86.
PMID: 28212870
Background: Inflammation is a key process underlying the clinical course of coronary artery disease (CAD). C-reactive protein (CRP) and interleukin-6 (IL-6) contribute to its pathophysiology and act as biomarkers. We...
6.
Milkas A, Tsioufis K, Dimitriadis K, Lazaros G, Kordalis A, Thomopoulos K, et al.
Hellenic J Cardiol
. 2016 Feb;
57(1):59-61.
PMID: 26856205
No abstract available.
7.
Alexopoulos D, Kochiadakis G, Afthonidis D, Barbetseas J, Kelembekoglou P, Limberi S, et al.
Int J Cardiol
. 2016 Jan;
205:111-116.
PMID: 26730841
Objective: Primary objectives were to evaluate tolerability, compliance, and perception of ranolazine effectiveness for chronic stable angina in a routine clinical setting. The secondary objective was safety evaluation. Methods: Prospective,...
8.
Toutouzas K, Anousakis-Vlachochristou N, Patsa C, Matsoukis I, Drakopoulou M, Tsiamis E, et al.
Int J Cardiol
. 2015 Feb;
183:27-32.
PMID: 25662050
Background: New-generation drug-eluting stents have demonstrated the mid-term efficacy and safety, but possible differences between stents may emerge in a long-term period. We compared long-term outcomes of patients with chronic...
9.
Toutouzas K, Patsa C, Synetos A, Karanasos A, Karampelas J, Tsiamis E, et al.
Hellenic J Cardiol
. 2011 Apr;
52(2):103-10.
PMID: 21478119
Introduction: The impact of drug-eluting stents (DES) has not been extensively investigated in patients with moderate to severe renal dysfunction, as these patients are consistently excluded from randomised studies. We...
10.
Syrseloudis D, Tsioufis C, Aragiannis D, Soulis D, Stefanadi E, Spanos A, et al.
Am J Hypertens
. 2010 Dec;
24(3):292-8.
PMID: 21127469
Background: Blood pressure (BP) nondipping has been associated with target-organ damage (TOD) and adverse outcomes in hypertension. Diverse definitions of nondipping status appear in the literature, regarding the BP components...